Literature DB >> 1446055

Immunohistochemical reaction to human milk fat globule antibodies and breast cancer differentiation.

E E Sterns1, W A Fletcher, B Zee.   

Abstract

Immunohistochemical studies of human breast cancers using human milk fat globule (HMFG) antibodies are divergent regarding the association with histologic differentiation. To clarify this association 392 tumors were assessed using two antibodies, HMFG-1 and HMFG-2. In half the tumors studied the tissue reaction to both antibodies was the same and in 63% the site of reaction was identical. Using both univariate and multivariate statistics, a highly significant association was recorded between membrane staining and well differentiated cancers and cytoplasmic staining and poor differentiation. Well differentiated tumors contained significantly more reactive cells. Complementing these findings was the association between age at diagnosis, tumor stage, and estrogen receptor status and differentiation. It is possible that immunohistochemical analysis with HMFG antibodies will provide better characterization of tumor differentiation than morphologic interpretation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1446055     DOI: 10.1007/bf01831478

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  19 in total

1.  A new antigen on the epithelial membrane: its immunoperoxidase localisation in normal and neoplastic tissue.

Authors:  E Heyderman; K Steele; M G Ormerod
Journal:  J Clin Pathol       Date:  1979-01       Impact factor: 3.411

2.  Studies on milk fat globule membranes.

Authors:  R M Dowben; J R Brunner; D E Philpott
Journal:  Biochim Biophys Acta       Date:  1967-02-01

3.  Use of monoclonal antibodies for the histopathological diagnosis of human malignancy.

Authors:  K C Gatter; Z Abdulaziz; P Beverley; J R Corvalan; C Ford; E B Lane; M Mota; J R Nash; K Pulford; H Stein; J Taylor-Papadimitriou; C Woodhouse; D Y Mason
Journal:  J Clin Pathol       Date:  1982-11       Impact factor: 3.411

4.  Are prognostic factors for local control of breast cancer treated by primary radiotherapy significant for patients treated by mastectomy?

Authors:  P P Rosen; D W Kinne; M Lesser; S Hellman
Journal:  Cancer       Date:  1986-04-01       Impact factor: 6.860

5.  Prognostic value of surface antigens in primary human breast carcinomas, detected by monoclonal antibodies.

Authors:  B B Rasmussen; B V Pedersen; S M Thorpe; J Hilkens; J Hilgers; C Rose
Journal:  Cancer Res       Date:  1985-03       Impact factor: 12.701

6.  Interobserver reproducibility of histopathological features in stage II breast cancer. An ECOG study.

Authors:  K W Gilchrist; L Kalish; V E Gould; S Hirschl; J E Imbriglia; W M Levy; A S Patchefsky; D W Penner; J Pickren; J A Roth
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

7.  Expression of differentiation antigens within human mammary tumours is related to response to endocrine therapy and survival.

Authors:  A D Baildam; A Howell; D M Barnes; J Redford; K Healy; R Swindell; R A Sellwood
Journal:  Int J Cancer       Date:  1988-08-15       Impact factor: 7.396

8.  Immunohistochemical characteristics of human milk-fat globule antibodies in predicting chest wall and distant metastasis after mastectomy for localized cancer of the breast.

Authors:  E E Sterns; W A Fletcher; B Zee
Journal:  Ann Surg       Date:  1992-11       Impact factor: 12.969

9.  Patterns of reaction of monoclonal antibodies HMFG-1 and -2 with benign breast tissues and breast carcinomas.

Authors:  J Taylor-Papadimitriou; R Millis; J Burchell; R Nash; L Pang; J Gilbert
Journal:  J Exp Pathol       Date:  1986

10.  Immunocytochemical staining of breast carcinoma with the monoclonal antibody NCRC 11: a new prognostic indicator.

Authors:  I O Ellis; C P Hinton; J MacNay; C W Elston; A Robins; A A Owainati; R W Blamey; R W Baldwin; B Ferry
Journal:  Br Med J (Clin Res Ed)       Date:  1985-03-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.